ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 109 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $57,141,898 | +11.6% | 6,144,290 | +18.9% | 0.00% | 0.0% |
| Q1 2024 | $51,199,192 | +223.7% | 5,166,417 | +5.5% | 0.00% | – |
| Q4 2023 | $15,815,736 | +3.4% | 4,896,513 | +70.0% | 0.00% | – |
| Q3 2023 | $15,289,933 | -39.5% | 2,879,460 | +8.6% | 0.00% | -100.0% |
| Q2 2023 | $25,258,197 | -11.1% | 2,650,388 | +2.6% | 0.00% | 0.0% |
| Q1 2023 | $28,403,441 | -24.2% | 2,582,131 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $37,464,898 | -13.0% | 2,531,412 | +12.4% | 0.00% | 0.0% |
| Q3 2022 | $43,053,000 | +12.3% | 2,252,939 | +25.3% | 0.00% | 0.0% |
| Q2 2022 | $38,329,000 | +30.0% | 1,798,663 | +17.5% | 0.00% | 0.0% |
| Q1 2022 | $29,489,000 | -6.1% | 1,531,098 | +1.1% | 0.00% | 0.0% |
| Q4 2021 | $31,408,000 | -11.9% | 1,514,328 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $35,648,000 | -12.6% | 1,492,207 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $40,779,000 | -7.8% | 1,494,276 | -2.3% | 0.00% | 0.0% |
| Q1 2021 | $44,250,000 | +44.7% | 1,529,570 | +40.7% | 0.00% | 0.0% |
| Q4 2020 | $30,581,000 | +21.8% | 1,087,133 | +26.8% | 0.00% | 0.0% |
| Q3 2020 | $25,115,000 | +120.0% | 857,166 | +127.0% | 0.00% | – |
| Q2 2020 | $11,418,000 | +118.4% | 377,581 | +115.3% | 0.00% | – |
| Q1 2020 | $5,227,000 | – | 175,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $305,003,000 | 24.46% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $115,121,000 | 6.52% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $16,462,000 | 5.28% |
| SECTORAL ASSET MANAGEMENT INC | 878,948 | $25,428,000 | 1.93% |
| Omega Fund Management, LLC | 623,836 | $18,048,000 | 1.71% |
| Orbimed Advisors | 6,073,850 | $175,716,000 | 1.64% |
| Altium Capital Management LP | 113,962 | $3,297,000 | 0.92% |
| Vivo Capital, LLC | 744,370 | $21,535,000 | 0.76% |
| Polar Capital Holdings Plc | 1,557,543 | $45,060,000 | 0.28% |
| Birchview Capital, LP | 9,000 | $260,000 | 0.15% |